Author: openjargon

The Emerald Resources NL (ASX: EMR) share price was in focus on Wednesday after the company revealed a record full-year profit of $259.6 million, driven by higher gold prices and disciplined operations. Revenue jumped 40% to $612.3 million, as gold production from Okvau reached more than 100,000 ounces with costs among the lowest in the sector.

What did Emerald Resources report?

• Revenue: $612.3 million, up 40% from FY25
• Net profit after tax (NPAT): $259.6 million, up 196%
• EBITDA: $392.1 million, up 93% year on year
• Gold production: 100,405 ounces at an all-in sustaining cost (AISC) of US$972/oz
• Cash, bullion and investments: $491.1 million at 30 June 2026
• Dividends: No dividend declared for FY26

What else do investors need to know?

Emerald remained debt-free and unhedged, cementing its position as a low-cost gold producer. Operational highlights included expanding reserves and robust gold recoveries from the Okvau mine in Cambodia, now totalling over 509,600 ounces since production began in 2021. Growth activities ramped up across both Cambodia and Australia, supported by a strong balance sheet.

Beyond Okvau, significant progress was made on the Dingo Range and Memot projects. Both are fully permitted, with maiden ore reserve estimates to follow and studies well underway. Exploration continues to deliver promising results, leading to resource upgrades and demonstrating future growth pathways.

What’s next for Emerald Resources?

Looking ahead to FY27, Emerald expects gold production of 100,000–115,000 ounces at Okvau, with similar AISC guidance and the addition of new feed sources through further drilling. Development is progressing for both the Dingo Range (Western Australia) and Memot (Cambodia) projects, with definitive feasibility studies nearing completion and first mining activities on track for the coming year.

Exploration remains a priority, with over 3.9 million ounces now in global resources across key projects. Emerald continues to target becoming a multi-mine, 300,000–400,000 ounce per annum gold producer, backed by a solid cash position and expanding project pipeline.

Emerald Resources share price snapshot

The Emerald Resources share price has risen strongly in the past 12 months, smashing the S&P/ASX 200 index (ASX: XJO) with a gain of almost 85%.

View Original Announcement

The post Emerald Resources FY26 earnings: Record profit on gold price surge appeared first on The Motley Fool Australia.

More reading

• Emerald Resources delivers solid Q4 production and advances key projects

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Sigma Healthcare Ltd (ASX: SIG) share price is in focus today after the company reported a 15.5% lift in revenue to $10.8 billion and a 20.6% surge in normalised EBIT to $1.09 billion for FY26, its first full-year result since merging with Chemist Warehouse Group.

What did Sigma Healthcare report?

• Revenue: $10.8 billion, up 15.5% year on year
• Normalised EBIT: $1,090.0 million, up 20.6%, with margin rising to 10.1%
• Normalised NPAT: $732.3 million, up 22.3%
• Net debt reduced to $663 million (Debt to Normalised EBITDA: 0.57x)
• Integration synergies delivered: $32.6 million, aiming for $100 million p.a. by FY29
• Fully franked final dividend: 2.0 cents per share (full year: 4.0 cents per share)

What else do investors need to know?

Sigma’s Australian business remains its “engine room”, contributing $10.4 billion in revenue and $1,034.2 million in normalised EBIT. The international arm is gathering momentum, delivering 33% revenue growth and doubling EBIT, with Ireland now profitable and a push into the UK market underway.

Sigma added 24 Chemist Warehouse branded stores in Australia, reaching 561 stores, while opening 20 new international outlets. The company continued to expand its own and exclusive-label products, with annual sales near $1 billion and the Wagner Pharmaceuticals generic business growing over 30%.

What did Sigma Healthcare management say?

Sigma’s CEO, Vikesh Ramsunder, said:

FY26 demonstrates that Sigma is not simply larger after the merger, it is structurally stronger. Our highly scalable business model is underpinned by defensive industry characteristics. With the Australian infrastructure already in place and a clearly defined runway to keep growing, we are confident the model will keep compounding value.

What’s next for Sigma Healthcare?

Sigma’s FY27 agenda centres on growing its network, driving operating leverage, and boosting product differentiation. The company aims to open 13 new Chemist Warehouse stores in Australia and 19 internationally in the first half, including its entry into the UK. Refreshed growth in the Amcal and Discount Drug Stores brands is also expected, with 42 new Australian stores on the way.

With a capital-light model and a solid balance sheet, Sigma is targeting sustained growth and long-term shareholder value, with over half of planned synergy savings still to be realised.

Sigma Healthcare share price snapshot

The Sigma Healthcare share price has underperformed the S&P/ASX 200 index (ASX: XJO) on a 12-month basis with a decline of almost 7%.

View Original Announcement

The post Sigma Healthcare FY26 earnings: Record profit as Chemist Warehouse merger delivers growth appeared first on The Motley Fool Australia.

More reading

• My top 5 ASX 200 shares to buy and hold
• Why I’d buy Coles, Telstra and this ASX 200 blue chip share for retirement
• ASX 200 technology and healthcare shares continued their comeback last week
• 3 ASX 200 blue-chip shares I’d buy now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Bapcor Ltd (ASX: BAP) share price is in focus today after the company reported a statutory net loss of $431.6 million in FY26, driven mainly by non-cash impairment charges, while underlying EBITDA exceeded the top end of May’s guidance.

What did Bapcor report?

• Underlying revenue of $1,924.1 million, down 1.8% from FY25
• Statutory net loss after tax of $431.6 million, impacted by $442.4 million in post-tax significant items
• Underlying EBITDA of $152.5 million, exceeding guidance
• Underlying NPAT of $10.8 million, down 85.0% year-on-year
• Net bank debt reduced to $135.0 million from $364.8 million in FY25
• No final dividend declared to prioritise cash during the turnaround

What else do investors need to know?

Bapcor’s FY26 was a year of transition and turnaround, marked by the appointment of a new CEO, Chair, and strengthened leadership team. The second half saw improved operating momentum, with working capital initiatives delivering $68.5 million in cash flow and cash conversion rising sharply to 109.4%.

The company completed a $200 million equity raising in February 2026, helping to materially strengthen its balance sheet and reduce net debt. Bapcor also implemented cost and efficiency improvements, focusing on enhancing price competitiveness, stock availability, and customer engagement across its business units.

What did Bapcor management say?

Chief Executive Officer and Managing Director, Chris Wilesmith, said:

Since joining Bapcor in January, our priority has been restoring the fundamentals of the business. The actions implemented during the second half improved performance across the Group. Sales momentum improved across the Group through the final 5 months of the year, Networks returned to growth, Retail delivering positive like-for-like sales growth, and our working capital initiatives are delivering real value.

What’s next for Bapcor?

Looking ahead, Bapcor plans to build on its recent improvements with an ongoing turnaround program and a broader strategic review to clarify long-term priorities. The company is also considering divesting smaller, non-core assets to sharpen its focus on critical, high-return businesses.

In FY27, management expects modest revenue growth with trading momentum tipped to improve further. Early trading for the first six weeks shows sales slightly ahead of last year, although macroeconomic and geopolitical uncertainties persist. Profits are likely to be more heavily weighted to the second half of the year.

Bapcor share price snapshot

Over the past 12 months, the Bapcor share price has significantly underperformed the S&P/ASX 200 Index (ASX: XJO) with an 85% decline as operational challenges weighed on investor sentiment.

View Original Announcement

The post Bapcor Ltd FY26 earnings: turnaround gains, big impairment loss appeared first on The Motley Fool Australia.

More reading

• Bapcor reaffirms FY26 EBITDA guidance
• Down 84%, why Bapcor shares may have further to fall
• 3 ASX All Ords shares to sell this week: Experts

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Perpetual Ltd (ASX: PPT) share price is in focus as the company reports a 6% rise in underlying profit after tax (UPAT) to $217 million and declares a final unfranked dividend of 63 cents per share.

What did Perpetual report?

• FY26 operating revenue of $1,374.2 million (flat year-on-year)
• UPAT of $217.0 million, up 6% from FY25
• Statutory net profit after tax (NPAT) of $88.9 million, recovering from a $58.2 million loss in FY25
• Corporate Trust profit before tax up 9% to $98.8 million
• Final dividend of 63 cents per share (unfranked); total FY26 dividends $1.22 per share (65% payout ratio)
• Annualised cost savings of $72.6 million delivered under the Simplification Program

What else do investors need to know?

Perpetual signed a binding agreement in March 2026 to sell its Wealth Management division to Bain Capital. This move is a key part of the company’s simplification strategy, with the transaction expected to complete in the final quarter of 2026, subject to regulatory approvals.

The group continued to reduce debt, lowering gross debt by 15% over the past year to $629.3 million. Proceeds from the Wealth Management sale are expected to further strengthen the balance sheet, supporting future investment in Asset Management and Corporate Trust.

Significant items after tax were $128.1 million, mainly related to transaction and separation costs from the Wealth Management sale, impairment charges, and costs tied to the ongoing Simplification Program.

What did Perpetual management say?

Perpetual CEO and Managing Director Bernard Reilly said:

FY26 was a positive year despite mixed market conditions. We delivered strong earnings growth and improved profitability against a backdrop of geopolitical uncertainty and corporate change, highlighting the benefits of our diversified business model.

What’s next for Perpetual?

Perpetual’s top priority is completing the sale of Wealth Management, marking a further step in its transition to a simpler organisation. After the sale, Perpetual plans to focus on its Asset Management and Corporate Trust businesses—aiming for consistent earnings, a stronger balance sheet, and greater financial flexibility.

Perpetual is also pursuing ongoing cost efficiencies and digital transformation in Corporate Trust and is targeting fresh product innovation and global growth in Asset Management, including a turnaround plan for its J O Hambro boutique.

Perpetual share price snapshot

The Perpetual share price has underperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a decline of almost 12%.

View Original Announcement

The post Perpetual posts higher FY26 profit and readies for business sale appeared first on The Motley Fool Australia.

More reading

• Perpetual reveals $63.5m impairment after major fund redemption
• These were the best-performing ASX 200 shares in July
• Perpetual lifts AUM, advances Wealth sale in Q4 FY26 update

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

ASX mining shares like South32 Ltd (ASX: S32) are a popular choice among Australian investors looking for passive income.

The attraction is simple. When commodity prices are strong, large-scale miners can generate a huge amount of cash and return a good portfolio to their shareholders in the form of dividends.

But what exactly would it entail to earn the passive income you want?

Let’s take a look at what it takes to earn $6,000 off South32 shares in FY26.

What passive income does South32 pay its shareholders?

First, we need to understand what dividends the mining giant pays its shareholders.

South32 typically pays its investors twice-yearly dividends: an interim dividend in April and a final dividend in October.

South32 paid a fully-franked interim dividend of 3.9 US cents (equivalent to 5.52 AUD cents) per share in April.

As part of its FY26 results announcement this morning, the miner declared another final 5.4 US cent (equivalent of 7.5 AU cents) dividend will be paid to shareholders in October. 

That comes to a total FY26 dividend of 9.3 US cents (equivalent of 13 AU cents) per security.

At the time of writing, this translates to a dividend yield of around 1.8% for FY26. 

So, how many South32 shares do I need to generate $6,000 of passive income every year?

Using the FY26 total dividend payment of 13 cents per share, investors would need to own around 46,154 South32 shares in order to earn $6,000 in passive income.

What would that cost me?

At the time of writing, South32 shares are $5.14 each.

That means, in order to buy the 46,154 shares needed for $6,000 of annual passive income in FY26, you would need to invest roughly $237,231. 

It’s not a small amount, but it could be worth it in the long run.

And remember, you don’t need to invest the entire amount in one go. Start off small and let compound growth do some of the work for you.

Could South32 shares climb higher in value this year?

The experts are optimistic about the outlook for South32 shares over the next 12 months.

Market Index shows the majority of brokers have a buy rating on the mining stock. But the $4.94 average target price now implies a potential 4% downside ahead.

Sentiment is also mostly positive on TradingView. The data shows that the majority of analysts (seven out of 14) have a buy/strong buy rating on the shares. Another six rate South32 shares as a hold.

But after the latest rally, the average $4.77 target price now implies a potential downside of around 7%, at the time of writing. 

The post How many South32 shares do I need to buy for $6,000 per year of passive income? appeared first on The Motley Fool Australia.

More reading

• South32 FY26 earnings: base metals drive profit surge and new dividend
• 5 things to watch on the ASX 200 on Thursday
• South32, Woolworths, BHP shares reach 52-week high: Buy, sell or hold?
• South32 share price in focus as Sierra Gorda mine life jumps with 61% reserve boost
• Bell Potter names the best ASX shares to buy in August

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Qantas Airways Ltd (ASX: QAN) share price is in focus today after the company posted a statutory profit after tax of $1.29 billion and declared a final fully franked dividend of 19.8 cents per share for FY26.

What did Qantas Airways report?

• Underlying Profit Before Tax: $2.06 billion, down $330 million from FY25
• Statutory Profit After Tax: $1.29 billion, down $316 million
• Final dividend: 19.8 cents per share (fully franked), total FY26 dividends $600 million
• Underlying earnings per share: 96 cents, down 14 cents
• Net capital expenditure: $4.0 billion, up 3%
• 17 new aircraft delivered during the year

What else do investors need to know?

Qantas continued to invest heavily in new aircraft and training facilities, marking the largest fleet renewal in its history. The group opened a new training centre in Mascot as part of a $100 million upgrade.

Around 25,000 eligible non-executive employees will each receive $1,000 in Qantas shares, following another year of meeting financial targets. Qantas Loyalty delivered strong results, with a 12% increase in underlying EBIT and record engagement from frequent flyers.

Net debt increased to $6.2 billion, remaining within management’s target range. The Board cancelled a planned $150 million share buy-back as part of its capital management.

What did Qantas Airways management say?

Commenting on the results, Qantas’ CEO, Vanessa Hudson, said:

This has been another year of progress, with customer satisfaction at its highest in a decade and world-leading operational performance, even as the aviation industry faced record high fuel costs and disruption from the conflict in the Middle East. We came through it with a strong result, which is what allows us to continue investing in the largest fleet renewal in our history and deliver more for our customers, people and shareholders.

What’s next for Qantas Airways?

Qantas expects domestic and international travel demand to remain resilient, with capacity growth and new routes on the horizon in FY27. The group will receive its first Project Sunrise A350-1000ULR in April, and the first non-stop Sydney-London flight will launch in October.

Management forecasts unit revenues to grow by 8–10% in the first half of FY27, despite ongoing pressure from elevated fuel prices. Qantas Loyalty earnings are expected to increase by 5–7% next year, and investment in new aircraft and employee training will continue.

Qantas Airways share price snapshot

Over the past 12 months, the Qantas Airways share price has underperformed the S&P/ASX 200 index (ASX: XJO) with a decline of almost 20%.

View Original Announcement

The post Qantas Airways share price on watch as FY26 profit dips but dividend and upgrades unveiled appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• 2 ASX 200 shares I’d buy and 2 I’d avoid amid a surging Aussie dollar
• Are Qantas shares good value this week?
• 2 ASX travel stocks to buy and one to sell
• 8 ASX 200 shares with renewed buy ratings this week

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Two of the most influential ASX defence stocks released half-year results yesterday: Droneshield Ltd (ASX: DRO) and Elsight Ltd (ASX: ELS). 

These companies are involved in the defence sector, which boomed on the back of tailwinds through 2025 and into 2026. 

However, since then, it hasn’t been all smooth sailing. 

How the tables have turned

Defence-related ASX shares surged in 2025 as investors anticipated sustained growth in global military spending.

Ongoing conflicts, strategic competition, and a growing focus on national security reinforced expectations of stronger demand for defence equipment, cybersecurity, surveillance systems, and advanced military technologies.

However, the share prices of many ASX defence stocks have reversed course in recent months. 

This decline has largely reflected profit-taking and a reset in valuations after a strong rally, with investors becoming less willing to pay the high premiums built on expectations of sustained defence spending growth.

One stock hit harder than almost any other has been DroneShield shares. Once fetching over $6, DroneShield shares have come crashing back to earth in 2026. 

Its stock price is down 45% year to date and is now hovering around $1.70. 

Meanwhile, Elsight shares have continued to steadily grow. 

Its share price is up more than 220% in the last 12 months. 

Why Elsight shares are a buy

Despite moving in such different directions this year, the team at Bell Potter has similar optimism about both companies over the next 12 months. 

Following the half-year results, the broker has a buy recommendation on Elsight shares along with a price target of $8.20. 

From current levels, this indicates an upside potential of 42%. 

We believe ELS has developed a market leading product that is leveraged to the proliferation of unmanned systems in both a defence and commercial context. We believe ELS shares offer relative value versus listed peers at 33x CY26e EV/EBIT given its recurring revenue, high ROIC business model and defensible niche.

Elsight’s half-year report can be found here.

DroneShield shares a bounce-back candidate

After crashing in 2026, the team at Bell Potter believes DroneShield shares could be a value at its current price. 

Following its results, the team at Bell Potter issued a new report on the company. 

The broker has a buy recommendation and $2.40 (previously $2.50) price target on DroneShield shares. 

From yesterday’s closing price, this indicates an upside of 38%. 

We expect RFRecon and new high-moat next gen products to drive continued contract wins, particularly from Europe where DRO has a leading presence in the CUAS EW vertical. Top end of CY26 revenue guidance looks achievable. Retain Buy.

The post Defence Duel: Are Elsight or DroneShield shares a better buy right now? appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• Down 48% in 2026: Have DroneShield shares finally bottomed out?
• Why I’d buy the dip on DroneShield and WiseTech shares
• Are DroneShield shares a buy, sell or hold following their half-year FY26 results today?
• Why Woolworths, Domino’s and DroneShield shares are turning heads on Wednesday

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Mesoblast Ltd (ASX: MSB) share price is in focus after the company reported a sharp increase in revenue to US$120.3 million for the 2026 financial year and a 44% reduction in net loss.

What did Mesoblast report?

• Total revenue climbed to US$120.3 million, up from US$17.2 million in FY2025
• Gross profit reached US$103.6 million, with gross profit excluding amortisation at US$109.7 million
• Net loss reduced by 44% to US$57.5 million, down from US$102.1 million last year
• Net operating cash spend was US$43.8 million, improved from US$50.0 million in FY2025
• Period-end cash balance stood at US$103 million with a new US$125 million five-year credit facility
• US commercial launch of RYONCIL generated US$115.2 million in net revenue

What else do investors need to know?

Mesoblast successfully launched RYONCIL in the US for children with steroid-refractory acute graft versus host disease, securing broad adoption at major paediatric transplant centres and major payer coverage. The median time from patient identification to treatment dropped from 29 days at launch to 8 days.

The company is expanding RYONCIL’s use to adults with severe SR-aGvHD, a market potentially three times larger than the paediatric segment, and progressing a registration trial as part of a second-line regimen with ruxolitinib. Mesoblast also obtained FDA clearance for a trial in children with Duchenne muscular dystrophy.

For its rexlemestrocel-L platform, Mesoblast completed treatment of 350 patients in a Phase 3 clinical trial for chronic low back pain, positioning the company to address a market worth over US$10 billion. Top-line results are expected in mid-2027.

What did Mesoblast management say?

Mesoblast’s CEO, Dr. Silviu Itescu, commented:

We are very pleased to report a strong full year gross profit of US$104M for the fiscal year 2026. The financial result is a product of continued growth in RYONCIL market adoption and focus on disciplined capital allocation while investing in our high-value opportunities.

What’s next for Mesoblast?

Looking ahead, Mesoblast plans to expand RYONCIL’s label to adults with severe SR-aGvHD and further advance development for chronic low back pain using rexlemestrocel-L, with a pivotal data readout due next year. The company also aims to develop next-generation cell therapies through new CAR-MSC and oncolytic virus technologies, broadening its pipeline for inflammatory and immunological diseases.

With a solid cash balance and new funding in place, Mesoblast intends to continue investing in high-value clinical programs and commercial execution, maintaining its position as a sector innovator.

Mesoblast share price snapshot

The Mesoblast share price has underperformed the S&P/ASX 200 index (ASX: XJO) with a decline of around 5% over the past 12 months.

View Original Announcement

The post Mesoblast earnings: Strong revenue growth and operational milestones in FY26 appeared first on The Motley Fool Australia.

More reading

• ASX 200 healthcare shares soar 9% amid notable FY26 reports from CSL, Pro Medicus
• Mesoblast shares are up sharply. Is this biotech still undervalued?
• Here are the top 10 ASX 200 shares today
• Mesoblast share price jumps on blockbuster news
• 3 ASX 200 shares tipped to grow 45% to 75% over the next 12 months

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Eagers Automotive Ltd (ASX: APE) share price could be in focus after the company delivered a record half-year result, with revenue rising 24% to $8.05 billion and net profit after tax up 23% to $165.2 million.

What did Eagers Automotive report?

• Revenue rose 24% to $8,053.5 million compared to 1H25
• Statutory net profit after tax increased 23% to $165.2 million
• Underlying EBITDA up 23% to $364.6 million
• Ordinary interim dividend up 4% to 25 cents per share, fully franked
• Liquidity at $2.61 billion and net debt at $674.9 million as at 30 June 2026
• Acquisition of CanadaOne Auto Group contributed $40.5 million in profit before tax across two months

What else do investors need to know?

Eagers Automotive entered the Canadian market by acquiring a 65% stake in CanadaOne Auto Group, which made an immediate positive impact on group results and expanded the company’s international footprint. The strategic investment saw the company issue exchangeable shares as partial consideration, strengthening the balance sheet and broadening shareholder alignment.

In Australia, Eagers increased its market share in new vehicles, reaching 15.9%, up from 13.8% a year ago. The group also signed a non-binding agreement to divest its franchised automotive business in New Zealand—retaining the easyauto123 operations—to redeploy capital into other growth initiatives.

What’s next for Eagers Automotive?

Eagers Automotive expects a full second-half contribution from CanadaOne Auto Group, with further opportunities for organic and acquisitive growth in North America. The company remains focused on optimising its partner portfolio, expanding its independent pre-owned vehicle business, and leveraging its unique scale and brand partnerships to outperform industry benchmarks.

Management cited a disciplined approach to capital allocation and cost management, aiming for sustainable, industry-leading returns. While mindful of current economic conditions and higher interest rates, the board remains optimistic about growth prospects in both the Australian and Canadian markets.

Eagers Automotive share price snapshot

The Eagers Automotive share price has modestly outperformed the S&P/ASX 200 index (ASX: XJO) on a 12-month basis with a gain of over 6%.

View Original Announcement

The post Eagers Automotive posts record 1H26 earnings on strong Canadian expansion appeared first on The Motley Fool Australia.

More reading

• How much superannuation is needed to target a $50,000 annual passive income?
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Eagers Automotive Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Brightstar Resources Ltd (ASX: BTR) share price is in focus after the company announced exceptionally wide, high-grade gold intercepts from infill drilling at its Two Mile Hill-Shillington deposit, part of the Sandstone Gold Project. Standout results include a 225.7 metre interval at 3.11 grams per tonne gold, with individual assays up to 449 grams per tonne.

What did Brightstar Resources report?

• Received further assay results from reverse circulation and diamond core drilling at Two Mile Hill-Shillington.
• Key intercepts include 225.7m @ 3.11g/t Au (including 19m @ 24.3g/t Au) and 194m @ 2.10g/t Au (including 13m @ 4.35g/t Au).
• Current Mineral Resource Estimate: 14.6 million tonnes at 1.6g/t Au for 731,000 ounces gold at Two Mile Hill-Shillington.
• Infill drilling targets areas for potential underground mining and aims to upgrade resources to Indicated classification.
• Visible gold was observed throughout significant intersections, typically associated with galena and pyrite.

What else do investors need to know?

Drilling at Sandstone is ongoing, with both RC and diamond rigs active across multiple deposits as part of workstreams for the pre-feasibility study. These latest results support Brightstar’s plans to potentially include underground mining in its upcoming study.

The infill drilling builds on recent success, following earlier results such as 305m at 1.8g/t Au from extension drilling. Initial work has also identified a newly discovered “Shirvington Zone” at Two Mile Hill, revealing even broader mineralisation than previously modelled.

What did Brightstar Resources management say?

Managing Director Alex Rovira said:

The latest results continue to demonstrate the broad widths of the Two Mile Hill deposit and high-grade nature of the quartz veining within the host tonalite, with individual grades reaching 449g/t Au. These infill results are hugely encouraging for a potential future underground mining operation at Two Mile Hill, which is currently being assessed by Brightstar and Entech for inclusion in the upcoming pre-feasibility study.

What’s next for Brightstar Resources?

Brightstar plans to incorporate the new infill drill results into its next Mineral Resource Estimate and pre-feasibility study, both set for release in November 2026. The ongoing drilling programs seek to further enhance geological confidence and explore extensions at depth.

Construction of the 1.5Mtpa processing plant is already underway as part of the broader Goldfields Hub development, with initial gold production targeted for June 2027. The company aims to progress towards large-scale underground and open pit mining across its Western Australian gold assets.

Brightstar Resources share price snapshot

Over the past 12 months, Brightstar Resources shares have risen 32%, outperforming the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post Brightstar Resources posts record gold drilling intercepts at Sandstone appeared first on The Motley Fool Australia.

More reading

• Brightstar Resources results: 4.5Moz gold resource and production plans advance
• Brightstar Resources provides Goldfields Project update as construction forges ahead
• Brightstar Resources drills thick gold intercepts to expand Sandstone scale

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.